Comparative Permeability of Human and Rabbit Corneas to Cyclosporin and Tritiated Water

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 5, 2002, Pages 419-427

  Van Der Bijl, Pieter ^a   Engelbrecht, A H ^a   Van Eyk, Armorél D ^a   Meyer, David ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; CREMOPHOR; CYCLOSPORIN; DIMETHYL SULFOXIDE; LIQUID NITROGEN; WATER; BENZALKONIUM; DRUG DERIVATIVE; GLYCEROL; IMMUNOSUPPRESSIVE AGENT; TRITIUM;

ADULT; AGED; ANALYSIS OF VARIANCE; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG DIFFUSION; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IN VITRO STUDY; MALE; NONHUMAN; RABBIT; STATISTICAL ANALYSIS; STEADY STATE; TRANSPORT KINETICS; ANIMAL; BIOLOGICAL MODEL; COMPARATIVE STUDY; CORNEA; CULTURE TECHNIQUE; DRUG EFFECT; FROZEN SECTION; METABOLISM; PERMEABILITY; TIME;

ANIMALS; BENZALKONIUM COMPOUNDS; CORNEA; CULTURE TECHNIQUES; CYCLOSPORINE; DIMETHYL SULFOXIDE; FEMALE; FROZEN SECTIONS; GLYCEROL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MODELS, BIOLOGICAL; PERMEABILITY; RABBITS; TIME FACTORS; TRITIUM; WATER;

EID: 0036779689     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/10807680260362704     Document Type: Article

References (40)

1. Bell, T.A.G., and Hunnisett, A.G. Cyclosporin A: tissue levels following topical and systemic administration to rabbits. Br. J. Ophthalmol. 70:852-855, 1986.
2. Wiederholt, M., Kössendrup, D., Schulz, W., and Hoffmann, F. Pharmacokinetics of topical cyclosporin A in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 27:519-524, 1986.
3. Cheeks, L., Kaswan, R.L., and Green, K. Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea. Curr. Eye Res. 11:641-649, 1992.
4. Mosteller, M.W., Gebhart, B.M., Hamilton, A.M., and Kaufman, E. Penetration of topical cyclosporine into the rabbit cornea, aqueous humor and serum. Arch. Ophthalmol. 103:101-102, 1985.
5. Maurice, D. The effect of the low blink rate in rabbits on topical drug penetration. J. Ocul. Pharmacol. Ther. 11:297-304, 1995.
6. Edelhauser, H.F., and Maren, T.H. Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors. Arch. Opthalmol. 106:1110-1115, 1988.
7. Watsky, M.A., Jablonski, M.M., and Edelhauser, H.F. Comparison of conjunctival and corneal surface areas in rabbit and human. Curr. Eye Res. May 7(5):483-486, 1988.
8. Inaba, K., Tanishima, T., and Hirosawa, K. Electron microscopic observations of Descemet's membrane of peripheral cornea. Jpn. J. Ophthalmol. 30:1-13, 1986.
9. Gipson, I.K., Spurr-Michaud, S.J., and Tisdale, A.S. Anchoring fibrils form a complex network in human and rabbit cornea. Invest. Ophthalmol. Vis. Sci. 28:212-220, 1987.
10. Wessel, H., Anderson, S., Fite, D., Halvas, E., Hempel, J., and SundarRaj, N. Type XII collagen contributes to diversities in human corneal and limbal extracellular matrices. Invest. Ophthalmol. Vis. Sci. 38:2408-2422, 1997.
11. Maurice, D.M., and Mishima, S. Ocular pharmacokinetics. In Pharmacology of the Eye, Sears, M.L., editor. Berlin, Heidelberg, New York, Tokyo, Springer-Verlag, 1984, pp 19-116.
12. Mishima, S. Clinical pharmacokinetics of the eye. Proctor lecture. Invest. Ophthalmol. Vis. Sci. 21:504-541, 1981.
13. Faulds, D., Goa, K.L., and Benfield, P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 45:953-1040, 1993.
14. de Smet, M.D., and Nussenblatt, R.B. Clinical use of cyclosporine in ocular disease. Int. Ophthalmol. Clin. 33:31-45, 1993.
15. Mochizuki, M., and de Smet, M.D. Use of immunosuppressive agents in ocular diseases. Prog. Retinal Eye Res. 13:479-506, 1994.
16. Kaswan, R.L. Intraocular penetration of topically applied cyclosporine. Transpl. Proc. 20(suppl. 2):650-655, 1988.
17. Llopis, M.D., and Menezo, J.I. Penetration of 2% cyclosporin eyedrops into human aqueous humor. Br. J. Ophthalmol. 73:600-603, 1989.
18. BenEzra, D., and Maftzir, G. Ocular penetration of cyclosporine A: the rabbit eye. Invest. Ophthalmol. Vis. Sci. 31:1362-1366, 1990.
19. BenEzra, D., and Maftzir, G. Ocular penetration of cyclosporin A in the rat eye. Arch. Ophthalmol. 108:584-587, 1990.
20. Bellot, J.L., Alió, J.L., Ruiz Moreno, J.M., and Artolo, A. Corneal concentration and systemic absorption of cyclosporin-A following its topical application in the rabbit eye. Ophthalmic. Res. 24:351-356, 1992.
21. Kanpolat, A., Batioglu, F., Yilmaz, M., and Akbas, F. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration. CLAO J. 20:119-122, 1994.
22. Oh, C., Saville, B.A., Cheng, Y.L., and Rootman, D.S. A compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits. Pharm. Res. 12:433-437, 1995.
23. Bonduelle, S., Carrier, M., Pimienta, C., Benoît, J., and Lenaerts, V. Tissue concentration of nanoencapsulated radiolabelled cyclosporin following peroral delivery in mice or ophthalmic application in rabbits. Eur. J. Pharm. Biopharm. 42:313-319, 1996.
24. BenEzra, D., Maftzir, G., de Courten, C., and Timonen, P. Ocular penetration of cyclosporin A. III: the human eye. Br. J. Ophthalmol. 74:350-352, 1990.
25. Secchi, A.G., Tognon, M.S., and Leonardi, A. Topical use of cyclosporin in the treatment of vernal keratoconjunctivitis. Am. J. Ophthalmol. 110:641-645, 1990.
26. Zierhut, M., Thiel, H.J., Weidle, E.G., Waetjen, R., and Pleyer, U. Topical treatment of severe corneal ulcers with cyclosporine A. Graefe's Arch. Clin. Exp. Ophthalmol. 227:30-35, 1989.
27. Chen, Y.F., Gebhardt, B.M., Reidy, J.J., and Kaufman, H.E. Cyclosporine-containing collagen shields suppress corneal allograft rejection. Am. J. Ophthalmol. 109:132-137, 1990.
28. Nussenblatt, R.B., Dinning, W.J., Fujikawa, L.S., Chan, C.C., and Palestine, A.G. Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch. Ophthalmol. 103:1559-1562, 1985.
29. Versura, P., Cellini, M., Zucchini, P.G., Caramazza, R., and Laschi, R. Ultrastructural and immunohistochemical study on the effect of topical cyclosporine A in the rabbit eye. Cornea 8:81-89, 1989.
30. Benítez Del Castillo, J.M., Castillo, A., Toledano, N., Duran, S., del Aguila, C., Otero, M., and Garcia-Sanchez, J. Influence of topical cyclosporine A and dissolvent on corneal epithelium permeability of fluorescein. Documenta Opththalmol. 91:49-55, 1995.
31. Mueller, D.W. Improved extemporaneous formulation of cyclosporine opthhalmic drops. Am. J. Hosp. Pharm. 51:3080-3081, 1994.
32. Van der Bijl, P., Van Eyk, A.D., and Meyer, D. Effects of three penetration enhancers on transcorneal permeation of Cyclosporine. Cornea 20(5):505-508, 2001.
33. Van der Bijl, P., Thompson, I.O.C., and Squier, C.A. Comparative permeability of human vaginal and buccal mucosa. Eur. J. Oral Sci. 105:571-575, 1997.
34. Van der Bijl, P., Van Eyk, A.D., and Thompson, I.O.C. Diffusion rates of vasopressin through human vaginal and buccal mucosa. Eur. J. Oral Sci. 106:958-962, 1998.
35. Van der Bijl, P., Penkler, L., and Van Eyk, A.D. Permeation of sumatriptan through human vaginal and buccal mucosa. Headache 40:137-141, 2000.
36. Grass, G.M., and Robinson, J.R. Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability. J. Pharm. Sci. 73:1021-1027, 1984.
37. Donn, A., Miller, S., and Mallet, N. Water permeability of the living cornea. Arch. Ophthalmol. 70:515-521, 1963.
38. Tang-Liu, D.D.S., Richman, J.B., Weinkam, R.J., and Takruri, H. Effects of four penetration enhancers on corneal permeability of drugs in vitro. J. Pharm. Sci. 83:85-90, 1994.
39. Tønjum, A.M. Permeability of rabbit corneal epithelium to horseradish peroxidase after the influence of benzalkonium chloride. Acta. Ophthalmol. 53:335-347, 1975.
40. Stern, M.E., Edelhauser, H.F., Krebs, S.J., Carney, G.R., and Hiddeman, J.W. A comparison of corneal epithelial and endothelial toxicity of common ophthalmic preservatives. ARVO Abstracts. Invest. Ophthalmol. Vis. Sci. 24 (Suppl): 156, 1983.